"Under the terms of Amendments to the parties' 2016 Development and License Agreement (the "Agreement"), Elite and SunGen will share the responsibilities and costs of development. Three products will be owned jointly by Elite and SunGen; three shall be owned by SunGen while Elite shall have the marketing rights once the products are approved by the FDA; and two shall be owned by Elite while SunGen shall have the marketing rights once the products are approved by the FDA. Elite will manufacture and package all eight products on a cost plus basis.
The product classes for the additional four products include antidepressants, antibiotics, and antispasmodics. The additional four products and their generic equivalents had total U.S. sales of more than $1.4 billion in 2016 according to IMS Health Data. The original four products and their generic equivalents had total U.S. sales of more than $3 billion in 2016 according to IMS Health Data."
So this SunGen Pharma seems to be making quite a few agreements with Elite lately. Lucrative agreements at that.
Do not care that this is not a "Big Pharma". Dr Huang like Nasrat with Elite going for generics of a different nature.
Oh... to all of those who said generics were a thing of the past and will not make much money..... how much does promethazine HCL injection go for these days? Anyone? Promethazine injection is on the FDA shortage list.
Lots of different generics still make lots of money.